Tags

Type your tag names separated by a space and hit enter

Neuronal substance P-driven MRGPRX2-dependent mast cell degranulation products differentially promote vascular permeability.
Front Immunol. 2024; 15:1477072.FI

Abstract

Mas-related G protein-coupled receptor b2 (Mrgprb2) binding to its cationic endogenous and exogenous ligands induces mast cell degranulation and promotes inflammation in mice. However, the physiological roles of its human homologue MRGPRX2 remain unclear. Here we aimed to elucidate the mechanisms by which MRGPRX2 regulates vascular permeability, and generated MRGPRX2 knock-in (MRGPRX2-KI) and Mrgprb2 knockout (Mrgprb2-KO) mice. Substance P (SP) and ciprofloxacin strongly degranulated MRGPRX2-KI peritoneal mast cells (PMCs) better than WT PMCs, whereas Dermatophagoides pteronyssinus (Der p) extract and phenol-soluble modulin α3 (PSMα3) did not degranulate PMCs. SP-stimulated MRGPRX2-KI PMCs released large amounts of histamine and mast cell protease 4 (MCPT4) chymase. Der p extract, PSMα3, and MCPT4, but not histamine, induced SP release from dorsal root ganglion (DRG) cells. However, this effect of Der p extract/PSMα3 was suppressed by a transient receptor potential vanilloid 1 (TRPV1) antagonist. SP-, ciprofloxacin-, Der p extract-, PSMα3-, and MCPT4-induced vascular permeability was highest in MRGPRX2-KI mice, which depended on SP. In addition, SP-, ciprofloxacin- and PSMα3-induced MRGPRX2-dependent vascular hyperpermeability was suppressed by antihistamine and chymase inhibitor. TRPV1 antagonist also inhibited PSMα3-induced MRGPRX2-dependent vascular hyperpermeability. Both Mrgprb2-KO and MRGPRX2-KI did not influence the histamine-induced murine vascular hyperpermeability. Overall, our results suggest that neuronal SP induces MRGPRX2-dependent mast cell degranulation, releasing histamine and chymase, which promote vascular hyperpermeability directly or indirectly via DRG cell activation. Importantly, the worsening cycle (MRGPRX2 → mast cell degranulation → chymase → DRG activation → SP → MRGPRX2) seems to play an important role in human MRGPRX2-depdendent inflammation.

Authors+Show Affiliations

Department of Science of Allergy and Inflammation, Juntendo University Graduate School of Medicine, Tokyo, Japan. Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan. Department of Otorhinolaryngology, Juntendo University Graduate School of Medicine, Tokyo, Japan.Department of Otorhinolaryngology, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.Department of Science of Allergy and Inflammation, Juntendo University Graduate School of Medicine, Tokyo, Japan. Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan. Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan. Department of Immunological Diagnosis, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan. Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.Department of Science of Allergy and Inflammation, Juntendo University Graduate School of Medicine, Tokyo, Japan. Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

39640264

Citation

Nagamine, Masakazu, et al. "Neuronal Substance P-driven MRGPRX2-dependent Mast Cell Degranulation Products Differentially Promote Vascular Permeability." Frontiers in Immunology, vol. 15, 2024, p. 1477072.
Nagamine M, Kaitani A, Izawa K, et al. Neuronal substance P-driven MRGPRX2-dependent mast cell degranulation products differentially promote vascular permeability. Front Immunol. 2024;15:1477072.
Nagamine, M., Kaitani, A., Izawa, K., Ando, T., Yoshikawa, A., Nakamura, M., Maehara, A., Yamamoto, R., Okamoto, Y., Wang, H., Yamada, H., Maeda, K., Nakano, N., Shimizu, T., Ogawa, H., Okumura, K., & Kitaura, J. (2024). Neuronal substance P-driven MRGPRX2-dependent mast cell degranulation products differentially promote vascular permeability. Frontiers in Immunology, 15, 1477072. https://doi.org/10.3389/fimmu.2024.1477072
Nagamine M, et al. Neuronal Substance P-driven MRGPRX2-dependent Mast Cell Degranulation Products Differentially Promote Vascular Permeability. Front Immunol. 2024;15:1477072. PubMed PMID: 39640264.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Neuronal substance P-driven MRGPRX2-dependent mast cell degranulation products differentially promote vascular permeability. AU - Nagamine,Masakazu, AU - Kaitani,Ayako, AU - Izawa,Kumi, AU - Ando,Tomoaki, AU - Yoshikawa,Akihisa, AU - Nakamura,Masahiro, AU - Maehara,Akie, AU - Yamamoto,Risa, AU - Okamoto,Yoko, AU - Wang,Hexing, AU - Yamada,Hiromichi, AU - Maeda,Keiko, AU - Nakano,Nobuhiro, AU - Shimizu,Toshiaki, AU - Ogawa,Hideoki, AU - Okumura,Ko, AU - Kitaura,Jiro, Y1 - 2024/11/21/ PY - 2024/08/07/received PY - 2024/10/30/accepted PY - 2024/12/6/medline PY - 2024/12/6/pubmed PY - 2024/12/6/entrez KW - MRGPRX2 KW - chymase KW - degranulation KW - histamine KW - mast cell KW - sensory neuron KW - substance P KW - vascular permeability SP - 1477072 EP - 1477072 JF - Frontiers in immunology JO - Front Immunol VL - 15 N2 - Mas-related G protein-coupled receptor b2 (Mrgprb2) binding to its cationic endogenous and exogenous ligands induces mast cell degranulation and promotes inflammation in mice. However, the physiological roles of its human homologue MRGPRX2 remain unclear. Here we aimed to elucidate the mechanisms by which MRGPRX2 regulates vascular permeability, and generated MRGPRX2 knock-in (MRGPRX2-KI) and Mrgprb2 knockout (Mrgprb2-KO) mice. Substance P (SP) and ciprofloxacin strongly degranulated MRGPRX2-KI peritoneal mast cells (PMCs) better than WT PMCs, whereas Dermatophagoides pteronyssinus (Der p) extract and phenol-soluble modulin α3 (PSMα3) did not degranulate PMCs. SP-stimulated MRGPRX2-KI PMCs released large amounts of histamine and mast cell protease 4 (MCPT4) chymase. Der p extract, PSMα3, and MCPT4, but not histamine, induced SP release from dorsal root ganglion (DRG) cells. However, this effect of Der p extract/PSMα3 was suppressed by a transient receptor potential vanilloid 1 (TRPV1) antagonist. SP-, ciprofloxacin-, Der p extract-, PSMα3-, and MCPT4-induced vascular permeability was highest in MRGPRX2-KI mice, which depended on SP. In addition, SP-, ciprofloxacin- and PSMα3-induced MRGPRX2-dependent vascular hyperpermeability was suppressed by antihistamine and chymase inhibitor. TRPV1 antagonist also inhibited PSMα3-induced MRGPRX2-dependent vascular hyperpermeability. Both Mrgprb2-KO and MRGPRX2-KI did not influence the histamine-induced murine vascular hyperpermeability. Overall, our results suggest that neuronal SP induces MRGPRX2-dependent mast cell degranulation, releasing histamine and chymase, which promote vascular hyperpermeability directly or indirectly via DRG cell activation. Importantly, the worsening cycle (MRGPRX2 → mast cell degranulation → chymase → DRG activation → SP → MRGPRX2) seems to play an important role in human MRGPRX2-depdendent inflammation. SN - 1664-3224 UR - https://www.unboundmedicine.com/medline/citation/39640264 DB - PRIME DP - Unbound Medicine ER -